We are live on ! Find out more
CVS icon

CVS Health

1,752 hedge funds and large institutions have $73.4B invested in CVS Health in 2025 Q1 according to their latest regulatory filings, with 277 funds opening new positions, 535 increasing their positions, 758 reducing their positions, and 170 closing their positions.

New
Increased
Maintained
Reduced
Closed

185% more funds holding in top 10

Funds holding in top 10: 1337 (+24)

63% more first-time investments, than exits

New positions opened: 277 | Existing positions closed: 170

55% more capital invested

Capital invested by funds: $47.3B → $73.4B (+$26.1B)

5% more funds holding

Funds holding: 1,6681,752 (+84)

2.63% more ownership

Funds ownership: 83.3%85.93% (+2.6%)

7% more call options, than puts

Call options by funds: $2.18B | Put options by funds: $2.05B

29% less repeat investments, than reductions

Existing positions increased: 535 | Existing positions reduced: 758

Holders
1,752
Holders Change
+84
Holders Change %
+5.04%
% of All Funds
23.49%
Holding in Top 10
37
Holding in Top 10 Change
+24
Holding in Top 10 Change %
+184.62%
% of All Funds
0.5%
New
277
Increased
535
Reduced
758
Closed
170
Calls
$2.18B
Puts
$2.05B
Net Calls
+$135M
Net Calls Change
-$187M
Name Holding Trade Value Shares
Change
Change in
Stake
BG
701
Bollard Group
Massachusetts
$1.47M +$15.1K +252 +1%
WBWA
702
William B. Walkup & Associates
South Carolina
$1.43M +$27.4K +458 +2%
WSC
703
Wellington Shields & Co
New York
$1.43M -$97.4K -1,627 -7%
ISB
704
Iowa State Bank
Iowa
$1.43M +$165K +2,761 +15%
CAM
705
Cresset Asset Management
Illinois
$1.43M -$262K -4,379 -17%
BMO
706
Beck Mack & Oliver
New York
$1.42M +$32.2K +538 +3%
HPC
707
HM Payson & Co
Maine
$1.42M -$80.3K -1,342 -6%
EFS
708
Essex Financial Services
Connecticut
$1.4M +$9.93K +166 +0.8%
EH
709
Equitable Holdings
New York
$1.39M -$2.51M -41,884 -67%
IRC
710
Investors Research Corp
Georgia
$1.39M +$25.4K +425 +2%
RCAG
711
Rehmann Capital Advisory Group
Michigan
$1.38M +$99.2K +1,658 +9%
VI
712
Versor Investments
New York
$1.38M +$664K +11,100 +121%
MAS
713
Meeder Advisory Services
Ohio
$1.37M +$225K +3,761 +23%
CAG
714
Crestwood Advisors Group
Massachusetts
$1.36M +$39.1K +653 +3%
GT
715
Greenleaf Trust
Michigan
$1.35M +$180K +3,000 +18%
S
716
SignatureFD
Georgia
$1.35M +$362K +6,048 +44%
ECM
717
Evergreen Capital Management
Washington
$1.35M +$454K +7,579 +62%
LA
718
Lynch & Associates
Indiana
$1.35M +$4.49K +75 +0.4%
EGM
719
Engineers Gate Manager
New York
$1.35M -$42.7M -714,218 -97%
LCM
720
Logan Capital Management
Pennsylvania
$1.34M +$136K +2,267 +13%
KCM
721
Kennondale Capital Management
Virginia
$1.34M
GT
722
Glenview Trust
Kentucky
$1.34M -$658K -11,000 -36%
SF
723
Slagle Financial
Illinois
$1.33M +$1.17M +19,559 New
WC
724
Wynn Capital
Georgia
$1.32M +$31.7K +530 +3%
RPC
725
Rossmore Private Capital
Connecticut
$1.32M -$187K -3,127 -14%

CVS Hedge Fund Activity: Q1 2025 in Review

1,752 of the 7,457 institutional investors tracked by Wall St. Rank reported a position in CVS Health (CVS) for Q1 2025, worth a combined $73.4B — up 55% from $47.3B a quarter earlier.

Buyers outnumbered sellers: 277 funds opened new CVS positions and 170 closed out — a net gain of 107 holders — while 535 added to existing stakes and 758 trimmed.

The largest buyer was Capital Research Global Investors, adding an estimated $971M. The largest seller was Hotchkis & Wiley Capital Management, cutting an estimated $309M.

  • 1,752 institutional investors held CVS Health (CVS) as of Q1 2025, up from 1,668 in Q4 2024.
  • Funds reported $73.4B of CVS Health stock for Q1 2025, up 55% quarter-over-quarter.
  • 277 funds opened new CVS Health positions in Q1 2025 and 170 closed out, a net change of +107 holders.
  • The largest CVS Health buyer in Q1 2025 was Capital Research Global Investors, an estimated $971M added.
  • The largest CVS Health seller in Q1 2025 was Hotchkis & Wiley Capital Management, an estimated $309M sold.

Based on aggregated 13F filings for Q1 2025.